Lee, Jong W; Pussegoda, Kusala; Rassekh, Rod S; Monzon, Jose G; Liu, Geoffrey; Hwang, Soomi; Bhavsar, Amit P; Pritchard, Sheila; Ross, Colin J; Carleton, Bruce C; Amstutz, Ursula (2016). Clinical Practice Recommendations For The Management And Prevention Of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers. Therapeutic drug monitoring, 38(4), p. 1. Lippincott Williams & Wilkins 10.1097/FTD.0000000000000298
|
Text
00007691-900000000-99186.pdf - Accepted Version Available under License Publisher holds Copyright. Download (881kB) | Preview |
Currently no pharmacogenomics-based criteria exist to guide clinicians in identifying individuals who are at risk of hearing loss from cisplatin-based chemotherapy. This review summarizes findings from pharmacogenomic studies that report genetic polymorphisms associated with cisplatin-induced hearing loss and aims to (1) provide up-to-date information on new developments in the field; (2) provide recommendations for the use of pharmacogenetic testing in the prevention, assessment and management of cisplatin-induced hearing loss in children and adults; and (3) identify knowledge gaps to direct and prioritize future research. These practice recommendations for pharmacogenetic testing in the context of cisplatin-induced hearing loss reflect a review and evaluation of recent literature and are designed to assist clinicians in providing optimal clinical care for patients receiving cisplatin based chemotherapy.
Item Type: |
Journal Article (Original Article) |
---|---|
Division/Institute: |
04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry |
UniBE Contributor: |
Amstutz, Ursula |
Subjects: |
600 Technology > 610 Medicine & health |
ISSN: |
0163-4356 |
Publisher: |
Lippincott Williams & Wilkins |
Language: |
English |
Submitter: |
Ursula Amstutz |
Date Deposited: |
24 May 2016 09:29 |
Last Modified: |
05 Dec 2022 14:54 |
Publisher DOI: |
10.1097/FTD.0000000000000298 |
PubMed ID: |
26960170 |
BORIS DOI: |
10.7892/boris.80349 |
URI: |
https://boris.unibe.ch/id/eprint/80349 |